Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Carestream’s Preclinical in Vivo Imaging Business to Be Acquired by Bruker

By BiotechDaily International staff writers
Posted on 05 Oct 2012
Carestream Health (Rochester, NY, USA) and Bruker Corp. (Billerica, MA, USA) have entered into an agreement for Bruker to purchase the preclinical in vivo imaging equipment product range and related assets from Carestream’s molecular imaging business. Financial terms of the agreement are not being disclosed.

Carestream will retain the remaining assets of its molecular imaging business, including its life science X-ray film product lines and its Gel Logic and Image Station in vitro imaging equipment-product range. Carestream will continue operating its life science X-ray film business, and will continue to support its in vitro product customers with service and parts. New production of its Gel Logic and Image Station in vitro products will be discontinued.

Dr. Werner Maas, president of Bruker BioSpin Corp., commented, “We are excited about adding Carestream’s in vivo imaging systems to our preclinical imaging product portfolio. We believe that Carestream’s optical molecular imaging product line will complement our other preclinical solutions, presently consisting of magnetic resonance imaging [MRI], magnetic particle imaging [MPI] and X-ray micro computed tomography [microCT]. We also welcome the talented Carestream in vivo employees to Bruker, and look forward to their contributions.”

Carestream Health is a worldwide provider of dental and medical imaging systems and healthcare information technology (IT) solutions; X-ray film and digital X-ray systems for nondestructive testing; and sophisticated materials for the precision films and electronics markets.

Bruker Corp. is a provider of scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis.

Related Links:
Carestream Health
Bruker



comments powered by Disqus

Channels

Genomics/Proteomics

view channel

New Program Encourages Wide Distribution of Genomic Data

A new data sharing program allows genomics researchers and practitioners to analyze, visualize, and share raw sequence data for individual patients or across populations straight from a local browser. The sequencing revolution is providing the raw data required to identify the genetic variants underlying rare diseases... Read more

Drug Discovery

view channel
Image: The nano-cocoon drug delivery system is biocompatible, specifically targets cancer cells, can carry a large drug load, and releases the drugs very quickly once inside the cancer cell. Ligands on the surface of the \"cocoon\" trick cancer cells into consuming it. Enzymes (the “worms\" in this image) inside the cocoon are unleashed once inside the cell, destroying the cocoon and releasing anticancer drugs into the cell (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Novel Anticancer Drug Delivery System Utilizes DNA-Based Nanocapsules

A novel DNA-based drug delivery system minimizes damage to normal tissues by utilizing the acidic microenvironment inside cancer cells to trigger the directed release of the anticancer drug doxorubicin (DOX).... Read more

Lab Technologies

view channel

Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells. Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.